Equitec Proprietary Markets’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
Equitec Proprietary Markets's SCPH Position: Q4 2025 in Review
Equitec Proprietary Markets sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 2,000 shares — an estimated $11.3K sold.
Equitec Proprietary Markets first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $11.3K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Equitec Proprietary Markets reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Equitec Proprietary Markets sold 2,000 scPharmaceuticals shares in Q4 2025, an estimated $11.3K.
- Equitec Proprietary Markets first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
- Equitec Proprietary Markets's scPharmaceuticals position peaked at $11.3K in Q3 2025.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Equitec Proprietary Markets's 13F filing for Q4 2025, filed 17 Feb 2026.